MediPharm Labs (TSE:LABS) Hits New 12-Month Low – Should You Sell?

Shares of MediPharm Labs Corp. (TSE:LABSGet Free Report) hit a new 52-week low during mid-day trading on Tuesday . The stock traded as low as C$0.06 and last traded at C$0.06, with a volume of 185410 shares. The stock had previously closed at C$0.07.

MediPharm Labs Price Performance

The company has a market cap of C$30.83 million, a P/E ratio of -1.88 and a beta of 0.88. The stock has a 50-day moving average of C$0.07 and a two-hundred day moving average of C$0.07. The company has a debt-to-equity ratio of 5.90, a quick ratio of 3.10 and a current ratio of 3.11.

MediPharm Labs Company Profile

(Get Free Report)

MediPharm Labs Corp., a pharmaceutical company, produces and sells pharmaceutical-quality cannabis oil and concentrates, and advanced derivative products in Canada and internationally. The company formulates, processes, packages, and distributes cannabis extracts and advanced cannabinoid-based products.

Featured Articles

Receive News & Ratings for MediPharm Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MediPharm Labs and related companies with MarketBeat.com's FREE daily email newsletter.